Microbiology of Severe Community-Acquired Pneumonia and the Role of Rapid Molecular Techniques

被引:3
作者
Pickens, Chiagozie I. [1 ,2 ]
Gao, Catherine A. [1 ]
Morales-Nebreda, Luisa [1 ]
Wunderink, Richard G. [1 ]
机构
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
关键词
pneumonia; community-acquired; molecular diagnostic; antibiotic; stewardship; INFECTIOUS-DISEASES SOCIETY; INVASIVE PNEUMOCOCCAL DISEASE; AMERICAN THORACIC SOCIETY; STAPHYLOCOCCUS-AUREUS; HOSPITALIZED-PATIENTS; PSEUDOMONAS-AERUGINOSA; BRONCHOALVEOLAR LAVAGE; TRACHEAL ASPIRATE; MINOR CRITERIA; ANTIGEN TEST;
D O I
10.1055/s-0043-1777770
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The microbiology of severe community acquired pneumonia (SCAP) has implications on management, clinical outcomes and public health policy. Therefore, knowledge of the etiologies of SCAP and methods to identify these microorganisms is key. Bacteria including Streptococcus pneumoniae, Staphylococcus aureus and Enterobacteriaceae continue to be important causes of SCAP. Viruses remain the most commonly identified etiology of SCAP. Atypical organisms are also important etiologies of SCAP and are critical to identify for public health. With the increased number of immunocompromised individuals, less common pathogens may also be found as the causative agent of SCAP. Traditional diagnostic tests, including semi-quantitative respiratory cultures, blood cultures and urinary antigens continue to hold an important role in the evaluation of patients with SCAP. Many of the limitations of the aforementioned tests are addressed by rapid, molecular diagnostic tests. Molecular diagnostics utilize culture-independent technology to identify species-specific genetic sequences. These tests are often semi-automated and provide results within hours, which provides an opportunity for expedient antibiotic stewardship. The existing literature suggests molecular diagnostic techniques may improve antibiotic stewardship in CAP, and future research should investigate optimal methods for implementation of these assays into clinical practice.
引用
收藏
页码:158 / 168
页数:11
相关论文
共 104 条
[1]   Panton-Valentine leukocidin-producing Staphylococcus aureus [J].
Adler, Amos ;
Temper, Violeta ;
Block, Colin S. ;
Abramson, Nitsa ;
Moses, Allon E. .
EMERGING INFECTIOUS DISEASES, 2006, 12 (11) :1789-1790
[2]   Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective [J].
Aliberti, Stefano ;
Cilloniz, Catia ;
Chalmers, James D. ;
Zanaboni, Anna Maria ;
Cosentini, Roberto ;
Tarsia, Paolo ;
Pesci, Alberto ;
Blasi, Francesco ;
Torres, Antoni .
THORAX, 2013, 68 (11) :997-999
[3]   Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia [J].
Amaro, Rosanel ;
Liapikou, Adamantia ;
Cilloniz, Catia ;
Gabarrus, Albert ;
Marco, Francesc ;
Sellares, Jacobo ;
Polverino, Eva ;
Garau, Javier ;
Ferrer, Miquel ;
Musher, Daniel M. ;
Torres, Antoni .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) :797-807
[4]   Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use [J].
Andrews, Denise ;
Chetty, Yumela ;
Cooper, Ben S. ;
Virk, Manjinder ;
Glass, Stephen K. ;
Letters, Andrew ;
Kelly, Philip A. ;
Sudhanva, Malur ;
Jeyaratnam, Dakshika .
BMC INFECTIOUS DISEASES, 2017, 17
[5]   In-house nucleic acid amplification assays in research: How much quality control is needed before one can rely upon the results? [J].
Apfalter, P ;
Reischl, U ;
Hammerschlag, MR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (12) :5835-5841
[6]   Etiology of community-acquired pneumonia [J].
Apisarnthanarak, A ;
Mundy, LM .
CLINICS IN CHEST MEDICINE, 2005, 26 (01) :47-+
[7]   Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa -: Incidence, risk, and prognosis [J].
Arancibia, F ;
Bauer, TT ;
Ewig, S ;
Mensa, J ;
Gonzalez, J ;
Niederman, MS ;
Torres, A .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (16) :1849-1858
[8]   Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns [J].
Assefa, Muluneh .
PNEUMONIA, 2022, 14 (01)
[9]   Diagnostic Tests for Agents of Community-Acquired Pneumonia [J].
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 :S296-S304
[10]   ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA IN OUT-PATIENTS [J].
BERNTSSON, E ;
LAGERGARD, T ;
STRANNEGARD, O ;
TROLLFORS, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :446-447